AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,281 | -3.2% | 16,510 | +20.5% | 0.00% | – |
| Q2 2023 | $132,584 | +56.4% | 13,697 | +77.1% | 0.00% | – |
| Q1 2023 | $84,751 | +70.4% | 7,733 | -32.6% | 0.00% | – |
| Q4 2022 | $49,734 | -47.6% | 11,476 | -9.1% | 0.00% | – |
| Q3 2022 | $95,000 | -43.5% | 12,629 | -24.9% | 0.00% | – |
| Q2 2022 | $168,000 | -26.3% | 16,819 | -9.1% | 0.00% | – |
| Q1 2022 | $228,000 | -49.9% | 18,493 | -7.5% | 0.00% | -100.0% |
| Q4 2021 | $455,000 | +15.2% | 19,986 | +11.7% | 0.00% | 0.0% |
| Q3 2021 | $395,000 | -11.0% | 17,890 | -47.9% | 0.00% | 0.0% |
| Q2 2021 | $444,000 | +75.5% | 34,359 | +77.0% | 0.00% | 0.0% |
| Q1 2021 | $253,000 | -59.7% | 19,413 | -57.2% | 0.00% | -50.0% |
| Q4 2020 | $628,000 | +120.4% | 45,391 | +134.8% | 0.00% | +100.0% |
| Q3 2020 | $285,000 | +2.9% | 19,330 | +13.5% | 0.00% | 0.0% |
| Q2 2020 | $277,000 | +166.3% | 17,030 | +136.5% | 0.00% | – |
| Q1 2020 | $104,000 | – | 7,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |